These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 9569196

  • 1. A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency.
    Zöller B, García de Frutos P, Dahlbäck B.
    Thromb Haemost; 1998 Apr; 79(4):802-7. PubMed ID: 9569196
    [Abstract] [Full Text] [Related]

  • 2. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT, Wiman B, Vettore S, Dazzi F, Girolami A, Patrassi GM.
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [Abstract] [Full Text] [Related]

  • 3. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
    Stegnar M, Uhrin P, Peternel P, Mavri A, Salobir-Pajnic B, Stare J, Binder BR.
    Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
    [Abstract] [Full Text] [Related]

  • 4. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis.
    Akhter MS, Biswas A, Ranjan R, Meena A, Yadav BK, Sharma A, Saxena R.
    Clin Appl Thromb Hemost; 2010 Apr; 16(2):184-8. PubMed ID: 19419975
    [Abstract] [Full Text] [Related]

  • 5. The study of gene-environment interactions that influence thrombosis and fibrinolysis. Genetic variation at the loci for factor VII and plasminogen activator inhibitor-1.
    Humphries SE, Lane A, Dawson S, Green FR.
    Arch Pathol Lab Med; 1992 Dec; 116(12):1322-9. PubMed ID: 1456879
    [Abstract] [Full Text] [Related]

  • 6. The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome.
    Tàssies D, Espinosa G, Muñoz-Rodríguez FJ, Freire C, Cervera R, Monteagudo J, Maragall S, Escolar G, Ingelmo M, Ordinas A, Font J, Reverter JC.
    Arthritis Rheum; 2000 Oct; 43(10):2349-58. PubMed ID: 11037896
    [Abstract] [Full Text] [Related]

  • 7. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.
    Deng A, Gocke CD, Hess J, Heyman M, Paltiel M, Gaspari A.
    Arch Dermatol; 2006 Nov; 142(11):1466-9. PubMed ID: 17116837
    [Abstract] [Full Text] [Related]

  • 8. [Relationship between polymorphisms of plasminogen activator inhibitor-1 promoter gene and pulmonary thromboembolism in Chinese Han population].
    Zhai ZG, Wang C, Yang YH, Pang BS, Xiao B, Liu YM, Mao YL, Weng XZ.
    Zhonghua Yi Xue Za Zhi; 2006 May 23; 86(19):1313-7. PubMed ID: 16796899
    [Abstract] [Full Text] [Related]

  • 9. [Genetic variations in plasminogen activator inhibitor-1 gene and beta fibrinogen gene associated with glomerular microthrombosis in lupus nephritis and the gene dosage effect].
    Gong R, Liu Z, Chen Z, Li L.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Feb 23; 19(1):1-5. PubMed ID: 11836675
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary artery disease.
    Grancha S, Estellés A, Tormo G, Falco C, Gilabert J, España F, Cano A, Segui R, Aznar J.
    Thromb Haemost; 1999 Apr 23; 81(4):516-21. PubMed ID: 10235431
    [Abstract] [Full Text] [Related]

  • 13. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism, coronary thrombosis, and myocardial infarction in middle-aged Finnish men who died suddenly.
    Mikkelsson J, Perola M, Wartiovaara U, Peltonen L, Palotie A, Penttilä A, Karhunen PJ.
    Thromb Haemost; 2000 Jul 23; 84(1):78-82. PubMed ID: 10928474
    [Abstract] [Full Text] [Related]

  • 14. Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence.
    Sundquist K, Wang X, Svensson PJ, Sundquist J, Hedelius A, Larsson Lönn S, Zöller B, Memon AA.
    Thromb Haemost; 2015 Nov 25; 114(6):1156-64. PubMed ID: 26245493
    [Abstract] [Full Text] [Related]

  • 15. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction.
    Fu L, Jin H, Song K, Zhang C, Shen J, Huang Y.
    Chin Med J (Engl); 2001 Mar 25; 114(3):266-9. PubMed ID: 11780311
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the plasminogen activator inhibitor-1 4G/5G gene polymorphism in females with venous thromboembolism during pregnancy or spontaneous abortion.
    Schenk JF, Stephan B, Zewinger S, Speer T, Pindur G.
    Clin Hemorheol Microcirc; 2008 Mar 25; 39(1-4):329-32. PubMed ID: 18503142
    [Abstract] [Full Text] [Related]

  • 17. The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctus du Mycocarde.
    Ye S, Green FR, Scarabin PY, Nicaud V, Bara L, Dawson SJ, Humphries SE, Evans A, Luc G, Cambou JP.
    Thromb Haemost; 1995 Sep 25; 74(3):837-41. PubMed ID: 8571307
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome].
    Reshetniak TM, Ostriakova EV, Patrusheva NL, Patrushev LI, Aleksandrova EN, Seredavkina NV, Volkov AV, Nasonov EL.
    Ter Arkh; 2013 Sep 25; 85(1):76-84. PubMed ID: 23536951
    [Abstract] [Full Text] [Related]

  • 20. PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus.
    Funk M, Endler G, Exner M, Marculescu R, Endler L, Abrahamian H, Mauler H, Grimm A, Raith M, Mannhalter C, Prager R, Irsigler K, Wagner OF.
    Wien Klin Wochenschr; 2005 Oct 25; 117(19-20):707-10. PubMed ID: 16416371
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.